WILMINGTON – The Zimmer Cancer Center at New Hanover Regional Medical Center has again been awarded a three-year approval with commendations as a teaching cancer hospital by the Commission on Cancer of the American College of Surgeons.
Twenty-five percent of hospitals in the United States have cancer programs approved by the Commission on Cancer and 80 percent of newly diagnosed cancer patients are treated in these institutions.
Approval by the Commission on Cancer is given only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and have submitted to a rigorous evaluation process and review of their performance. As a result of this review, NHRMC’s Zimmer Cancer Center received additional commendation in the following areas: Outcomes Analysis, Quality of NCDB data submission, AJCC Staging, Clinical Trials Accrual and Prevention and Early Detection.
Dr. Cyrus Kotwall, Medical Director of the Zimmer Cancer Center said, “Being recognized as a teaching hospital is a prestigious honor that requires stringent compliance and a high level of expertise. We are fortunate to have the components in place to support this designation, thanks to the oversight of the Oncology Advisory Committee as well as our physicians, nurses and ancillary staff.”
Receiving care at a Commission on Cancer-approved hospital ensures that a patient will have access to state-of-the-art services and equipment, a multi-specialty team approach to coordinate the best treatment options, information about ongoing clinical trials and new treatment choices, access to cancer-related information, education and support, a cancer registry that collects data on type and stage of cancers, treatment results and lifelong
patient follow-up, ongoing monitoring and improvement of care and, most importantly, quality care close to home.
Beth Mathews, RN, Director of the Zimmer Cancer Center, said, “Quality cancer care is a collaborative effort that happens because of a committed staff caring for both inpatients and outpatients at the cancer center.”